Table 2 Mutation status in ET and transformed AML cells.
UPN | Mutation | VAF (%) | |
---|---|---|---|
ET | AML | ||
1 | CALRK385fs*47 ASXL1G643fs TP53C238S U2AF1Q157R | 22.8 5.1 - - | 34.2 4.7 37.4 33.2 |
2 | CALRL367fs*43 MPLS505N TP53C153Y NRASQ61K | 51.0 39.0 3.0 - | 47.0 45.0 93.0 2.0 |
3 | MPLW515L TP53R248Q EZH2G660R PHF6G306E | 75.1 14.1 18.1 27.8 | 88.0 83.9 40.1 - |
4 | JAK2V617F TP53H178P | 18.4 - | 95.7 96.7 |
5 | JAK2V617F TET2Q1030* TET2C1271fs ASXL1E773* RUNX1L98fs CEBPAP23fs | 32.5 40.3 36.0 37.3 - - | 50.1 49.6 47.6 53.1 46.6 40.8 |
6 | JAK2V617F TET2Q278* TP53M133K IDH2R140Q NRASG12S | 68.5 10.3 - - - | - 48.3 82.4 45.5 6.4 |
7 | JAK2V617F TET2R1262L TET2H1380Y TP53R280S SRSF2P95R CBLG413D | 84.0 41.8 43.4 - - - | 9.9 60.0 34.2 77.6 73.8 67.1 |
8 | JAK2V617F TP53R248W TP53V173L SMARCC2D381E UBR4R450H ZNF143S286R | 40.5 4.7 4.4 50.7 47.7 47.9 | 2.7 87.5 3.5 47.9 48.5 60.6 |